跳至主要内容
临床试验/NCT04784039
NCT04784039尚未招募4 期

D-Dimer-based Indication for Transesophageal Echocardiography to Exclude Left Atrial Thrombus Before Cardioversion of Non-anticoagulated Atrial Fibrillation: A Multicenter Belgian Study

AZ Sint-Jan AV0 个研究点目标入组 1,368 人开始时间: 2025年1月1日最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
入组人数
1,368
主要终点
Incidence in thromboembolic events between both groups after 4 weeks follow-up

研究概览

简要总结

This trial aims at evaluating the number of thromboembolic events post cardioversion in patients receiving a direct current cardioversion with either prior transesophageal echocardiography or D-Dimer (DD) analysis.

Patients in need of a direct current cardioversion (DCCV), meeting the criteria for DCCV with prior transesophageal echocardiography (TEE), will be asked to participate in the CARDDI-BEL study.

Patients will be randomized on a 1:1 ratio to the TEE-group or DD-group. Patients in the TEE-group will receive TEE prior to cardioversion to exclude left atrial thrombus according to current guidelines [1]. In patients randomized to the DD-group, D-Dimer will be analyzed (cut-off defined by DDage). If the DDage > 10x patient's age, the analysis is suggestive for the presence of left atrial thrombus and the cardioversion will be performed with prior TEE. In case of negative DDage, no TEE will be used in the DD-group.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients older than 18 years
  • Patients with non-valvular atrial fibrillation scheduled for direct current cardioversion with prior TEE according to current guidelines
  • Patients willing to sign informed consent

排除标准

  • Cardiac surgery within the previous 90 days.
  • Coronary percutaneous transluminal coronary angioplasty/stenting within the previous 90 days or myocardial infarction within the previous 60 days.
  • Significant congenital anomaly or other medical problem that in the opinion of the investigator would preclude enrollment
  • History of blood clotting disease or bleeding abnormalities.
  • Patients with valve implants
  • Women who are pregnant
  • Aortic aneurysm or dissection
  • Documented history of deep vein thrombosis within the last 6 months
  • Documented history of pulmonary embolism within the last 6 months
  • Unwilling or unable to provide informed consent.
  • Recent transient ischemic attack or stroke (90 days)
  • Instable angina

结局指标

主要结局

Incidence in thromboembolic events between both groups after 4 weeks follow-up

时间窗: up to 4 weeks after cardioversion

The number of thromboembolic events (stroke, transient ischemic attack, ...) in the TEE and DD-group will be compared

次要结局

  • Correlation between D-Dimer-value (ng/L) and number of thrombi visible on TEE(Procedure (At time of cardioversion))
  • Correlation of DD-value (ng/L) with flow velocity (m/s) in case of spontaneous contrast or suspicion of thrombus in left atrial appendage(Procedure (At time of cardioversion))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sebastien Knecht

Principal Investigator

AZ Sint-Jan AV

相似试验